drugset / Trial / NCT01102270

The Effect of Eszopiclone on the Arousal Threshold in Sleep Apnea Syndrome

NCT01102270

RandomizedCrossoverTriple-blindBasic science

Summary

The purpose of this study is to find out whether taking eszopiclone (Lunesta) changes the breathing effort required to briefly wake people with obstructive sleep apnea from sleep (respiratory arousal threshold). We would like to see if taking eszopiclone can reduce the severity of obstructive sleep apnea in some people (those that have a low respiratory arousal threshold; i.e. wake up easily to respiratory stimuli).

Timeline

Start
2009-01
Primary completion
2009-08
Completion
2010-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Eszopiclone Small molecule 3 mg